Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Times Interest Earned (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Times Interest Earned readings, the most recent being -$9.36 for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned fell 312.53% year-over-year to -$9.36, compared with a TTM value of $0.11 through Dec 2025, up 102.8%, and an annual FY2025 reading of $0.11, up 102.8% over the prior year.
  • Times Interest Earned hit -$9.36 in Q4 2025 for Apellis Pharmaceuticals, down from $19.79 in the prior quarter.
  • The five-year high for Times Interest Earned was $37.96 in Q4 2022, with the low at -$74.5 in Q4 2021.
  • Median Times Interest Earned over the past 5 years was -$13.26 (2022), compared with a mean of -$15.71.
  • The sharpest move saw Times Interest Earned tumbled 650.24% in 2021, then skyrocketed 624.49% in 2025.
  • Year by year, Times Interest Earned stood at -$74.5 in 2021, then soared by 150.95% to $37.96 in 2022, then crashed by 130.08% to -$11.42 in 2023, then surged by 80.13% to -$2.27 in 2024, then crashed by 312.53% to -$9.36 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$9.36, $19.79, and -$2.98 for Q4 2025, Q3 2025, and Q2 2025 respectively.